Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 123 (1) , 118-126
- https://doi.org/10.1053/gast.2002.34164
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Liver BiopsyNew England Journal of Medicine, 2001
- The Role of Liver Biopsy in Chronic Hepatitis CHepatology, 2001
- Practice Parameter for the Use of Fresh-Frozen Plasma, Cryoprecipitate, and PlateletsJAMA, 1994
- Fine‐needle liver biopsy in patients with severely impaired coagulationLiver International, 1993
- Hemostasis in Advanced Liver DiseaseSeminars in Thrombosis and Hemostasis, 1993
- Plasma Protein C as a Marker of Hepatocellular Damage in Alcoholic Liver DiseasePathophysiology of Haemostasis and Thrombosis, 1992
- Effect of recombinant human FVIIA on warfarin-induced bleeding in ratsThrombosis Research, 1990
- Cirrhotics with variceal hemorrhage: The importance of the time interval between admission and the start of analysis for survival and rebleeding ratesHepatology, 1989
- Fresh-Frozen PlasmaPublished by American Medical Association (AMA) ,1985
- Clarification of Risk Factors for Abdominal Operations in Patients with Hepatic CirrhosisAnnals of Surgery, 1984